Loading clinical trials...
Loading clinical trials...
An Interventional, Open Label, Controlled, Randomized, Pairwise, Phase Ib Safety, Tolerability and Pharmacokinetic (PK) Study of Levofloxacin Ocular Implant in Patients Undergoing Routine Bilateral Cataract Surgery
Conditions
Interventions
Levofloxacin Ocular Implant
Control
Locations
3
United States
Ophthalmology Associates
St Louis, Missouri, United States
Carolina Cataract and Laser Centre
Ladson, South Carolina, United States
Melbourne Eye Specialists
Fitzroy, Victoria, Australia
Start Date
June 23, 2023
Primary Completion Date
December 15, 2023
Completion Date
March 14, 2024
Last Updated
April 12, 2024
NCT07452770
NCT06979752
NCT07362043
NCT06060041
NCT07325188
NCT07305987
Lead Sponsor
PolyActiva Pty Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions